The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; none of the 24 sources its claims cite is checked for support yet.
A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women
Open accessAbstract
Objective To evaluate the ovarian follicular dynamics of cycle modification with the aromatase inhibitor letrozole compared with clomiphene citrate in normal ovulatory women.Design Randomized double-blind controlled trial.Setting Tertiary care hospital.Patient(s) Nineteen ovulatory female volunteers, ages 18-35 years.Intervention(s) Subjects were monitored in one control cycle. Subjects then received either letrozole 2.5 mg daily or clomiphene citrate 50 mg daily on days 5-9 after menses.Main outcome measure(s) Number of mature follicles, endometrial thickness and endometrial pattern at ovulation, and follicular profiles of LH, FSH, and E(2).Result(s) The number of mature follicles at the LH surge in natural cycles was 1.0 with an exaggerated response seen for treatment both with clomiphene and letrozole. There was no difference in the endometrial thickness at midcycle during either the natural cycles or the medicated cycles. LH surges and spontaneous ovulation were documented in all natural and medicated cycles. When measured daily, follicular profiles of LH and FSH are similar between the groups in both the natural and medicated cycles. In the medicated cycles, clomiphene results in a significant increase in E(2) levels, while E(2) levels in letrozole-stimulated cycles appeared lower than in natural cycles.Conclusion(s) Transient inhibition of aromatase activity in the early follicular phase with the aromatase inhibitor letrozole results in stimulation of ovarian folliculogenesis similar to that seen with clomiphene citrate with no apparent adverse effect on endometrial thickness or pattern at midcycle.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In a randomized double-blind pilot of normal ovulatory women, letrozole 2.5 mg/day and clomiphene citrate 50 mg/day on cycle days 5–9 both increased mature follicles at the LH surge compared with natural cycles, with comparable midcycle endometrial thickness and spontaneous ovulation. Letrozole produced lower E2 levels than clomiphene and natural cycles, but the authors conclude larger trials are needed.
Key findings
- Sixteen participants completed both cycles. The mean (±SD) number of mature follicles (≥18 mm) at the LH surge was 2.2 (±0.67) in the clomiphene-treated group and 1.7 (±0.49) in the letrozole-treated group (P=.11); natural-cycle values were 1.0 in both groups.
- Midcycle endometrial thickness was comparable: natural cycle 9.8 (±1.6) mm with clomiphene vs 9.9 (±2.4) mm with letrozole (P=.91); treatment cycle 10.1 (±2.2) mm vs 10.6 (±2.0) mm (P=.64). No within-group difference between natural and treated cycles.
- Tri-laminar endometrium at midcycle was present in 100% (9/9) of letrozole natural cycles vs 56% (5/9) of clomiphene natural cycles; in treatment cycles it was 71% with letrozole (P=.46) and 44% with clomiphene (P=1.00). LH surges and spontaneous ovulation were documented in all natural and medicated cycles.
- At the LH surge, mean (±SD) E2 was 686 (±388) pmol/L with clomiphene vs 560 (±193) pmol/L with letrozole in natural cycles, and 2,047 (±930) pmol/L vs 399 (±167) pmol/L in stimulated cycles; clomiphene significantly increased E2, while letrozole E2 appeared lower than natural cycles.
Methods
- Randomized double-blind controlled pilot at Kingston General Hospital, October 1999–April 2000. Nineteen normal ovulatory women ages 18–35 who did not desire pregnancy were enrolled; inclusion required day 3 FSH ≤10 IU/L, normal hormonal profile, and reliable contraception.
- Each participant was monitored through one natural cycle, then randomized to letrozole 2.5 mg/day or clomiphene citrate 50 mg/day on days 5–9 after menses. Monitoring included daily LH, FSH, and E2 and transvaginal ultrasound.
- Primary outcome was number of mature follicles (≥18 mm) at the LH surge; additional outcomes included follicular E2/LH/FSH profiles, endometrial thickness and pattern 1 day after the LH surge, and spontaneous ovulation. Analysis used Student’s t-test and Fisher’s exact test, with P<.05 significant.
Limitations
- The paper states that no a priori power calculation was possible because letrozole had never been administered to premenopausal women; it was a small pilot designed before a larger trial in infertility patients. The authors also state that daily blood sampling may have been too infrequent to detect brief LH/FSH increases, and that whether lower E2 in letrozole cycles affects implantation or luteal function is unknown.
- The paper states that a larger randomized trial is required to fully assess letrozole’s impact on endometrial development.
- Evident from the text: only 16 of 19 enrolled women completed both cycles and were analyzed, and participants were normal ovulatory volunteers rather than infertile patients, so findings may not generalize to infertility or polycystic ovary syndrome populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
19 Own result · 15 Not checked yet · 10 Own method · 3 Own interpretation
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Early follicular treatment with clomiphene and letrozole resulted in a comparable increase in the number of mature follicles at the LH surge.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plaindirectn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the treatment cycle, the mean (ϮSD) midcycle endometrial thickness was 10.1 mm (Ϯ2.2 mm) in the clomiphene group and 10.6 mm (Ϯ2.0 mm) in the letrozole group (Pϭ.64,Student's t-test).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite significantly lower E 2 levels in letrozole-treated women, endometrial development was unaffected in this study.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > DISCUSSION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During the natural cycle, the mean (ϮSD) E 2 levels on the day of the LH surge were 686 (Ϯ388) pmol/L for the clomiphene group and 560 (Ϯ193) pmol/L for the letrozole group.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During the natural cycle, the mean (ϮSD) midcycle endometrial thickness in the clomiphene group was 9.8 mm (Ϯ1.6 mm) and in the letrozole group it was 9.9 mm (Ϯ2.4 mm; Pϭ.91, Student's t-test).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The number of mature follicles (Ն18 mm) at the LH surge in natural cycles was 1.0 in both the clomiphene and letrozole groups.”
- Also stated in: § Abstract · plain
“The number of mature follicles at the LH surge in natural cycles was 1.0 with an exaggerated response seen for treatment both with clomiphene and letrozole.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within each group, there was no difference in the mean endometrial thickness between the natural and treated cycles.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant reduction in the number of women with a midcycle tri-laminar pattern in either group during the treatment cycle (letrozole 71%, Pϭ.46, Fisher's exact test; and clomiphene 44%, Pϭ1.00, Fisher's exact test).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endometrial thickness at midcycle was comparable between the groups during both natural cycles and treatment cycles.”
- Also stated in: § Abstract · plain
“There was no difference in the endometrial thickness at midcycle during either the natural cycles or the medicated cycles.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 19- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the stimulated cycle, the mean (ϮSD) E 2 levels on the day of the LH surge were 2,047 (Ϯ930) pmol/L for the clomiphene group and 399 (Ϯ167) pmol/L for the letrozole group.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 13
- Probably not a substantial claim. 13
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When expressed as E 2 produced per follicle, clomiphene resulted in a slight increase in E 2 level per follicle, while letrozole resulted in a slight decrease in E 2 level per follicle compared with natural cycles (Fig. 4).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean (ϮSD) number of mature follicles in the clomiphene-treated group was 2.2 (Ϯ0.67), while that in the letrozole-treated group was 1.7 (Ϯ0.49) (Pϭ.11,Student's t-test).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the medicated cycles, clomiphene resulted in a significant increase in E 2 levels, while letrozole resulted in E 2 levels lower than those in natural cycles.”
- Also stated in: § Abstract · hedged
“In the medicated cycles, clomiphene results in a significant increase in E 2 levels, while E 2 levels in letrozole-stimulated cycles appeared lower than in natural cycles.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plaindirectn = 19- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § Abstract · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While all women in the letrozole group had tri-laminar pattern endometrium at midcycle in the natural cycle (100%), only 56% (5/9) of those in the clomiphene group had a tri-laminar pattern in the natural cycle.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LH surges and spontaneous ovulation were documented in all natural and medicated cycles.”
- Also stated in: § RESULTS · plain
“LH surges and spontaneous ovulation were documented in all natural and medicated cycles.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
plainn = 19- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § RESULTS · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of three women with a thin endometrium at midcycle in the treatment cycle, two women had received clomiphene (8 and 7.3 mm) and one had received letrozole (7.6 mm).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of interest, all of the women with a thin endometrium during the treatment cycle had greater endometrial thickness in the natural cycle (clomiphene group, 9.5 and 11.7 mm; letrozole group, 8.7 mm).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plaincorrelationaln = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Clomiphene results in a 60%-85% ovulation rate and a 10%-20% pregnancy rate per cycle (2)(3)(4)(5)(6)(7)(8).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [2] Dickey, 1996, Incidence of spontaneous abortion in clomiphene pregnancies, Hum Reprod source
- Not checked yetcites [3] Garcia, 1977, The use of clomiphene citrate, Fertil Steril source
- Not checked yetcites [4] Gorlitsky, 1978, Ovulation and pregnancy rates with clomiphene citrate, Obstet Gynecol source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Clomiphene citrate has been widely used in the treatment of infertility since its introduction into clinical practice in the 1960s (1).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [1] Greenblatt, 1961, Induction of ovulation with MRL/41, JAMA source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“and a significantly higher rate of biochemical pregnancies when the endometrial thickness was 6 -8 mm (15).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [15] Dickey, 1993, Relationship of biochemical pregnancy to preovulatory endometrial thickness and pattern in ovulation induction patients, Hum Reprod source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Letrozole (Femara; Novartis Pharmaceuticals, Dorval, Que ´bec, Canada) is a potent, reversible oral aromatase inhibitor that has recently been tested in phase 3 trials as a chemotherapeutic agent in postmenopausal women with metastatic breast cancer (17).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [17] Lamb, 1998, Letrozole, Drugs source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The Queen's University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board approved the study protocol.Study participants were counseled, and informed consent was obtained before randomization.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A total of 16 participants completed both cycles of the study and were included in the final analysis of data.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This pilot study was performed as a randomized doubleblind controlled investigation between October, 1999 and April, 2000 at Kingston General Hospital, Kingston, Ontario.”
- Also stated in: § Abstract · plain
“Design: Randomized double-blind controlled trial.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Also stated in: § Abstract · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Randomization was performed by choosing the next sequentially numbered opaque envelope prepared by the hospital pharmacy according to random number tables with randomization in blocks of four.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transient inhibition of aromatase activity in the early follicular phase with the aromatase inhibitor letrozole results in stimulation of ovarian folliculogenesis similar to that seen with clomiphene citrate with no apparent adverse effect on endometrial thickness or pattern at midcycle.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A single daily dose of 2.5 mg/day has been shown to achieve optimal suppression of serum estrogen levels in postmenopausal women (18).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [18] Dowsett, 1995, In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal women with breast cancer, Clin Cancer Res
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“One woman from the clomiphene group voluntarily withdrew from the study after completing the control cycle.Two women from the letrozole group failed to complete the study: 1 woman failed to ovulate in the control cycle and was withdrawn after randomization, and 1 woman voluntarily withdrew from the study before completion of the control cycle for personal reasons.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > RESULTS
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To accomplish blinding of the medications, the required daily doses of both letrozole and clomiphene were prepared by the hospital pharmacy in identical capsule form before randomization.Study investigators, radiologists, ultrasound technicians, and participants were unaware of study group allocation.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“When administered to normally cycling female rats, letrozole resulted in greater than 80% suppression of ovarian E 2 levels and caused a marked increase in LH and FSH, with a 35% increase in ovarian weights within 1 week of treatment (19).”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > Abstract
What the sources say
- Not checked yetcites [19] Sinha, 1998, Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat, Breast Cancer Res Treat source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“At the beginning of this study, letrozole had never been administered to premenopausal women, and neither the dose required to achieve suppression of ovarian aromatase nor the clinical effect of the chosen dose could be predicted.This precluded an a priori power calculation.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Samples from the control and stimulation cycle of each subject were always assayed in the same LH and FSH assay.”
§ A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women > MATERIALS AND METHODS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Letrozole does not cause estrogen receptor depletion.
“Because letrozole is more rapidly eliminated than clomiphene and does not cause estrogen receptor depletion, it is likely that letrozole may not cause the adverse endometrial effects observed with clomiphene, ultimately resulting in improved pregnancy rates.”
The paper relies on this without support.
Letrozole is more rapidly eliminated than clomiphene.
“Because letrozole is more rapidly eliminated than clomiphene and does not cause estrogen receptor depletion, it is likely that letrozole may not cause the adverse endometrial effects observed with clomiphene, ultimately resulting in improved pregnancy rates.”
The paper relies on this without support.
Clomiphene citrate is the current standard oral treatment for ovulation induction.
“The efficacy of letrozole was compared with clomiphene citrate, rather than placebo, to establish its equivalence to the current standard oral treatment for ovulation induction.”
The paper relies on this without support.
Normal ovulatory women are an appropriate model for evaluating letrozole before testing it in infertile women.
“This small pilot study was designed to evaluate the potential of letrozole as an ovulation induction agent before embarking on a larger trial involving infertility patients.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In superovulation, letrozole is associated with few developing follicles and thick endometrium.”
From A new era in ovulation induction (2006) · cites this paper as [53]
Citations
Cites
Mitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800
Self-citationAndrogens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Induction of Ovulation with MRL/41: Preliminary Report
Greenblatt, R. B. (1961) · JAMA · doi:10.1001/jama.1961.03040410001001 · Cited by 343
Vendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., & Bondy, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.353 · Cited by 324
Gonen, Y., & Casper, R. F. (1990) · Journal of In Vitro Fertilization and Embryo Transfer · doi:10.1007/bf01135678 · Cited by 307
Self-citationEffect of estrogen deprivation on the reproductive physiology of male and female primates
Shetty, G., Krishnamurthy, H., Krishnamurthy, H. N., Bhatnagar, A. S., & Moudgal, R. N. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80008-8 · Cited by 306
Gysler, M., March, C. M., Mishell, D. R., & Bailey, E. J. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46033-4 · Cited by 270
Dowsett, M., Jones, A. L., Johnston, S. R. D., Jacobs, S., Trunet, P. F., & Smith, I. E. (1995) · PubMed · Cited by 238
Garcia, J., Jones, G. S., & Wentz, A. C. (1977) · Fertility and Sterility · doi:10.1016/s0015-0282(16)42670-1 · Cited by 233
Research works printed but not linked: 1
- Mitwally, 2001, Aromatase inhibition decreases FSH dose needed during controlled ovarian hyperstimulation, J Soc Clin Invest, 8, 85A
Cited by
Sorted by citations
Items 201–300 of 347
A Case of Isolated Sphenoid Sinusitis with Orbital Complication and Maxillary Osteomyelitis
Maurya, D. R. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1264 · Cited by 1
Esthetic Rehabilitation with Immediate Implants in a Compromised Situation
Viswambaran, M., Dhiman, R. K., & Saini, D. K. (2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1117 · Cited by 1
Fertility Preservation, ART, and Breast Cancer
Revelli, A., Salvagno, F., Casano, S., Piane, L. D., & Benedetto, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-17278-1_4 · Cited by 1
Prosthetically Driven Implants: How much a Reality?
Gupta, H., Singh, A. V., & Panghal, V. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1091 · Cited by 1
Immediate Load Fiber Reinforced Hybrid Implant Prosthetics
Kurtzman, G. M., Grande, M., & Baroncini, C. V. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1072 · Cited by 1
Sundar, M. K., Lakhanpal, S., Pasha, M. F., & Gautam, A. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1100 · Cited by 1
Kalavathy, N., Dinesh, M., Shetty, M. M., Shetty, A., & Sridevi, J. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1045 · Cited by 1
Letrozole versus Clomiphene Citrate in Patients with Anovulatory Infertility
Paul, P., Gada, D., Parihar, M., & Bhowmik, S. (2009) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1038 · Cited by 1
“Major clinical studies have reported successful induction of ovulation with Letrozole.(3-7) Subsequently, few clinical studies have been undertaken in India, the findings of which have been presented in the annual conference of The Federation of Obstetric and Gynaecological Societies of India held in January 2003.”
BackgroundInfluentialEdlan-Mejchar Vestibular Deeping in a Failing Implant Case
Thomas, B., & Madani, S. M. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1103 · Cited by 1
Shayegh, S., Semyari, H., Shahraki, A. F., & Hakimaneh, S. M. R. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1076 · Cited by 1
Demystifying the Retrievability of Cement-retained Implant-supported Restorations
Mahesh, L., Nagrath, R., Lahori, M., & Kaushik, P. (2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1111 · Cited by 1
Latest Advances in Concepts and Treatment Protocols of Dental Implants: A Brief Review
Sarfaraz, H., & Chhabra, S. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1047 · Cited by 1
Denture Stabilization with Mini Dental Implants
Patel, P. B. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1042 · Cited by 2
Jain, N. V., Dugal, R., & Shinde, P. H. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1046 · Cited by 1
Singh, A. K., Tomar, S., & Verma, N. (2014) · Cited by 1
Mild Stimulation Protocol for Poor Ovarian Responders Undergoing IVF
Revelli, A., Casano, S., & Benedetto, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53454-1_16 · Cited by 1
Judicious Fertility Treatment to Minimise the Risk of Multiple Pregnancy
Langdon, F., & Hart, R. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79288 · Cited by 1
Parayaruthottam, P., & Antony, V. (2015) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1137 · Cited by 1
Cold Shoulder to Basal Implant: Its Time to Acknowledge Endosteal Implant
Shukla, V., Gajjar, D., Shukla, R., & Jain, S. R. (2015) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1140 · Cited by 1
Implant Retained Fixed Prosthesis
Kalavathy, N., Anantharaj, N., Kapoor, A., & Venkataramani, A. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1040 · Cited by 1
Mayer Rokitansky Küster Hauser Syndrome
Agarwal, V., & Borkar, S. (2014) · doi:10.5005/jp-journals-10058-0023 · Cited by 1
Bali, P., Gupta, G., Khashu, H., & Baiju, C. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1070 · Cited by 1
Fertilitätsstörungen und Sterilität
Ludwig, A. K., Diedrich, K., Ludwig, M. Z., & Felberbaum, R. E. (2006) · Springer eBooks · doi:10.1007/3-540-31105-x_12 · Cited by 1
Xi, Q., Liao, M., Wang, Y., Wang, B., Wang, Y., & Kuang, Y. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104077 · Cited by 1
Li, S., Long, Y., Wang, C., Yang, R., Lv, J., Chen, Z., Liu, J., Liu, H., & Cao, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1441796 · Cited by 1
Balakrishnan, D., Kalahasti, D., Hegde, V., & Narayana, A. I. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1073 · Cited by 1
Fertility Preservation Before Therapy for Cancer New Perspectives
Verma, S. (2006) · Apollo Medicine · doi:10.1016/s0976-0016(12)60089-1 · Cited by 1
Ivy, R., Chowdhury, A., Haque, K., & Ara, H. (1970) · Bangladesh Journal of Physiology and Pharmacology · doi:10.3329/bjpp.v25i1.5739 · Cited by 1
Objective Assessment of Implants Stability placed in Fresh Extraction Socket using Periotest Device
Goyal, M., & Saini, G. S. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1069 · Cited by 1
Lateral Sinus Augmentation: A Simplified Safer Approach
Kurtzman, G. M., & Dompkowski, D. F. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1098 · Cited by 1
Valcanaia, T. D. C., Bustamante, G. L., & Machado, R. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1083 · Cited by 1
Shrivastava, D., Gupta, M., Samal, S., Bagde, N., Mishra, N. K., & Gupta, S. (2017) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_14_17 · Cited by 6
Tandon, S., Giridher, V., & Juneja, A. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1262 · Cited by 1
Rare Case of Spindle Cell Carcinoma in Inverted Papilloma
Singh, S. K., Joshi, K. D., & Saxena, S. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1267 · Cited by 1
Yee, T., Khalid, S., Abu, M. A., Kadir, A., & Hashim, O. (2018) · SANAMED · doi:10.24125/sanamed.v13i2.241 · Cited by 1
“In future, we shall consider the usage of Letrozole (aromatase inhibitor) instead of CC that would not affect the endometrial thickness allowing fresh embryo transfer (21, 22).”
Kishk, E. A. (2019) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2019.33487 · Cited by 1
“Letrozole- unlike CC- has shorter half-life and thus has lower peripheral anti-estrogen effect[17] with little effect on endometrial thickness.”
BackgroundKannan, D., Kumar, L. B., & Subiksha, P. S. (2015) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1138 · Cited by 1
Kumar, D., Singh, S. K., Gupta, H., Agrawal, R., Natu, S. S., & Gupta, N. (2015) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1134 · Cited by 1
Ravichandran, R., & Kapoor, K. (2015) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1136 · Cited by 1
Desai, P., Vyas, A., Khare, E., & Dhiman, Y. (2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1120 · Cited by 1
Transverse Vaginal Septum: A Rare Case diagnosed during Labor
Kaur, K., Kaur, B., Kaur, A., & Gupta, R. (2014) · doi:10.5005/jp-journals-10058-0020 · Cited by 1
Rodriguez-Purata, J., Lee, J. K., Whitehouse, M. C., Sandler, B., Copperman, A. B., & Mukherjee, T. (2016) · PubMed · Cited by 1
Shafiq, A., Akbar, R., Urooj, U., Zohra, S., Afzal, S., & Tanveer, M. (2021) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v71i5.6554 · Cited by 1
Vishwakarma, M. B., Vakharia, S. D., Borade, V. R., Nagare, P. S., & Jaiswal, S. A. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1263 · Cited by 1
Yapura, M. J. (2013) · HARVEST (University of Saskatchewan) · Cited by 1
Fertilitätsstörungen und Sterilität
Beyer, D. A., Amari, F., Ludwig, A. K., Ludwig, M. Z., Felberbaum, R. E., & Diedrich, K. (2012) · Springer eBooks · doi:10.1007/978-3-642-20923-9_12 · Cited by 1
Aromatase inhibitors forfemaleinfertility treatment
Atay, V., Yaralı́, H., Bozdağ, G., Özışık, G., Akin, D., & Muhçu, M. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.2.137 · Cited by 1
“The authors concluded that AIs may be considered in ovulatory women for augmenting ovulation as efficacious as CC [20].”
BackgroundMethodEffects of Letrozole and Clomiphene citrate on ovarian stimulation in infertile women
Moslemizadeh, N., Payvandi, S., Khani, H., Farazmand, T., Olfati, N., Basirat, S., & Navaie, B. (2011) · Journal of North Khorasan University of Medical Sciences · doi:10.29252/jnkums.3.2.69
Physiologic Basis of Ovulation Induction
Casper, R. F. (2011) · doi:10.1002/9781444393958.ch11
Self-citationMild forms of ovarian stimulation
Aboulghar, M. A., & Rizk, B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.004
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547287.025
Panorama actual de los inhibidores de la aromatasa en la inducción de la ovulación
Pachón-Rincón, J. D. J., & Posada-Villa, N. (2007) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.476
“el desarrollo folicular y el perfil hormonal, con resultados favorables.(11) Además, varios estudios han evaluado el papel de los IA en pacientes anovulatorias con SOP resistentes a clomifeno(7) y en mujeres con infertilidad idiopática(12), mostrando buenos resultados.”
BackgroundAspects of Mono- and Multiple Dominant Follicle Development in the Human Ovary
Hohmann, F. P. (2005) · RePub (Erasmus University Rotterdam)
Possible additional therapeutic uses of aromatase inhibitors
Furr, B. J. A. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8693-1_9
“Similar results were seen in 19 ovulatory normal volunteers treated with either 2.5 mg of letrozole or 50 mg of clomiphene daily on days 5–9 after menstruation [ 25 ].”
ResultInfluentialZuk�nftige Wege der ovariellen Stimulation
Griesinger, G., Schultze-Mosgau, A., Felberbaum, R. E., & Diedrich, K. (2003) · Gynäkologische Endokrinologie · doi:10.1007/s10304-003-0037-2
‘Teeth in a Day’—An Innovative, Cost-Effective Technique for Immediate Loading of Implants
Sethi, S., Jambhekar, S. S., Kheur, M. G., & Kheur, S. M. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1066
Aromatasehemmer in der Therapie der Endometriose
Juhasz-Böss, I., Treeck, O., Malik, E., & Ortmann, O. (2006) · Gynäkologische Endokrinologie · doi:10.1007/s10304-006-0156-7
“Eine ovarielle Stimulation konnte in keinem der beiden Fälle gesichtet werden [34].”
BackgroundInfluentialPotential use of aromatase inhibitors in gynecology
Lukic, J., & Tulandi, T. (2006) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.1.1.41
Fertility preservation in young breast cancer patients: addressing individual patient needs
Rodriguez‐Wallberg, K. A., & Oktay, K. (2013) · Breast Cancer Management · doi:10.2217/bmt.12.68
Implantable Devices: A Review of Current Treatment Modalities
Jaggi, N., Bhutani, R., & Mehan, P. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1061
Balakrishnan, D., & Aparna, I. N. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1059
Tissue Stability following Soft-tissue Augmentation and Zirconia Prosthesis: A 6 Years Follow-up
Mahesh, L., Dhir, S., & Afrashtehfar, K. I. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1071
Implant Supported Overdenture: An Ameliorating Alternative for Edentulism
Govindwar, P. G., Dange, S. P., Khalikar, S. A., & Khalikar, A. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1092
Suresh, S. N., & Bhojaraju, N. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1034
Implant Supported Overdenture: An Ameliorating Alternative for Edentulism
Govindwar, P. G. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10021-1092
Mini Dental Implants as a Simple Treatment Alternative for Edentulous Mandibular Cases
Jacob, P. C., Rai, N., & Patil, D. P. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1042
Clinicoradiographic Evaluation and Feasibility of Dental Implant in Infected Dentoalveolar Socket
Batra, R. S., Rao, J. D., Vijaylaxmy, L. N. U., & Kukreja, A. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1039
Crestal Sinus Augmentation: A Simplified Approach to Implant Placement in the Posterior Maxilla
Kurtzman, G. M., & Dompkowski, D. F. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1036
Sagittal Distraction of Edentulous Maxillary Skeletal Base Prior to Implant Therapy
Kumar, V. V., & Malik, N. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1033
Nakamoto, T., Hosokawa, R., Murashima, Y., Masaki, C., Makino, M., & Kojo, T. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1028
Dhanalakshmi, G., Palaniswamy, S., & Pasupathy, P. (2012)
The Role of Implants in Orthodontics
Bhutani, R., & Mehan, P. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1062
Lateral Sinus Augmentation: A Safer Technique
Dompkowski, D. F., & Kurtzman, G. M. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1106
Implant Supported Mandible Over Denture with Four Implants Key Facts
Durrani, F. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1101
Jain, A. R. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1104
Transfer of Esthetic Gingival Contour for Anterior Implant Prosthetics
Kurtzman, D., Kurtzman, G. M., & Silverstein, L. H. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1052
Management of Bisphosphonate-related Osteonecrosis of the Jaw in an Elderly Lebanese Female
Abdallah, J. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1053
Timing of Implant Placement in Anterior Zone: A Clinical Perspective
Tunkiwala, B., & Tunkiwala, A. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1056
Implant and Tooth Supported Full-Mouth Rehabilitation with Hobo Twin-Stage Technique
Gupta, H., Singh, A. V., Tandon, K., & Paul, R. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1099
Khalikar, A., Vaidya, S. P., & Govindwar, P. G. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1084
Prashanth, N. T., Shobha, E. S., Kumar, R. D., & Verma, H. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1102
Guided Bone Ridge Augmentation: A Clinicohistologic and Radiographic 2 Years Follow-up
Mahesh, L., & Dhir, S. (2013) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1105
Natural Crown as Immediate Implant Provisional Prosthesis
(2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1112
Oviductal isthmus light microscopic changes induced by clomiphene citrate in albino rats
Mahdy, A. A. (2014) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000444079.55366.62
Aromatase Inhibitors in Clinical Gynecology
Onwubalili, N., & Cho, M. M. (2009) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000358041.98343.25
Sundar, M. K., & Lakhanpal, S. (2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1125
Immediate Loading of Dental Implants: Survival and Success Rate
Rathod, D. M., Dange, S., Khalikar, A., & Khalikar, S. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1027
Aromatase Inhibitors in the Treatment of Unexplained Female Infertility
Sekhon, L. H., Rekawek, P., & Grunfeld, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2140-9_26
Rai, S. A., Jeevan, C., & Jeevan, V. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1044
Ovulation induction for anovulatory patients
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.005
Implant-supported Overdenture using Resilient Reliner
Gupta, H., Singh, A. V., Priyadarshi, S., & Yusuf, S. M. (2015) · International Journal of Clinical Implant Dentistry · doi:10.5005/jp-journals-10004-1045
Reversal of Subgingival pH by Ascorbic Acid: A Weapon against Periopathogens
Dani, N., Joshi, C., Bhatt, V. H., Khanna, D., & Khedkar, S. (2014) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1124
An Introduction to the Longest Fixtures: Zygomatic Implants
Vikram, J., Anand, D., Sharma, R., & Hasti, A. (2016) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1155
Feline Dental Implants: New Paradigm Shift in Maxillary Cuspid Extraction Treatment Planning
Kurtzman, G. M., Mele, R. E., & Caiafa, A. (2016) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1156
Quand le clomiphène ne sera plus offert…
Tulandi, T., & Casper, R. F. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.06.024
Self-citationMetastasis of a Poorly Differentiated Endometrioid Carcinoma to the Maxillary Sinus: A Rare Report
Temmermand, D., Pavlenko, A., & Friedel, M. E. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1269
Lacrimal Gland Fistula: Report of a Rare Case
Singh, H. P., Usmani, S. A., & Verma, V. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1265
Bharadwaj, M., Singh, D. N., Sen, K., & Sharma, A. K. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1270
Accidental Partial Middle Turbinectomy: A Rare Complication of Nasal Intubation
Verma, D. K., Garg, U., Sharma, N., Makkar, S., & Bansal, P. (2017) · Otorhinolaryngology Clinics - An International Journal · doi:10.5005/jp-journals-10003-1266
Metadata
- Authors
- Fisher, S. A., Reid, R. L., Van Vugt, D. A., & Casper, R. F.
- Affiliations
- Queen's University (CA)
- University of Toronto (CA)
- Corresponding author
- Reid, Robert L
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 78
- Issue
- 2
- Pages
- 280-285
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2029278810
- Semantic Scholar
- 1a3a5d4d0b6f3798f147b32266da94b97f987fe1
- Cited by
- 347
- References
- 26
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 37 · 2016: 8 · 2015: 41 · 2014: 35 · 2013: 28 · 2012: 38
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- clomiphene citrate, letrozole, aromatase inhibitors, ovulation induction, ovarian follicle development, endometrial thickness, luteinizing hormone surge, follicle-stimulating hormone, estradiol
- MeSH terms
- Letrozole, Adolescent, Adult, Clomiphene, Double-Blind Method, Estrogen Antagonists, Fertility Agents, Female, Follicle Stimulating Hormone, Humans, Middle Aged, Nitriles, Ovulation, Pilot Projects, Triazoles, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
